한빛사904건

• • Athira Raveendran(전남대학교)

  • 서진희(전남대학교, Massachusetts General Hospital and Harvard Medical School)

  • 최학수(Massachusetts General Hospital and Harvard Medical School)

  • 조훈성(전남대학교)

  Lysosome-Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy

  • Adv. Sci. Sep 04 2024, | https://doi.org/10.1002/advs.202401424

  • 2024.09
  • 바이오·의료융합

• • 전희진(울산과학기술원)

  • 여미래(울산과학기술원)

  • 전준표(울산과학기술원)

  • 박성호(울산과학기술원)

  • 김은희(울산과학기술원)

  • 강세병(울산과학기술원)

  CD13-targeting and TRAIL-displaying protein nanoparticles effectively induce apoptotic cell death of acute myeloid leukemia, prolonging survival in mo

  • Nano Today Available online 4 September 2024 | https://doi.org/10.1016/j.nantod.2024.102474

  • 2024.09
  • 생명과학

• • 응우엔(성균관대학교)

  • 윤유석(성균관대학교)

  STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy

  • Bioact. Mater. Available online 6 September 2024; 42,345?365 | https://doi.org/10.1016/j.bioactmat.2024.09.002

  • 2024.09
  • 바이오·의료융합

• • 김상연(가톨릭대학교 의과대학, 주식회사 네오나)

  • 나민정(가톨릭대학교 의과대학, 주식회사 네오나)

  • 남석우(가톨릭대학교 의과대학 병리학교실, 주식회사 네오나)

  The roles and mechanisms of coding and noncoding RNA variations in cancer

  • Exp. Mol. Med. 02 September 2024 | https://doi.org/10.1038/s12276-024-01307-x

  • 2024.09
  • 생명과학

• • Terrence T. Roh(University of Illinois Urbana-Champaign, GSK plc)

  Predicting DNA damage response in non-small cell lung cancer organoids via simultaneous label-free autofluorescence multiharmonic microscopy

  • Redox Biol. Sep 2024, 75 103280 S2213-2317(24)00258-1 | https://doi.org/10.1016/j.redox.2024.103280

  • 2024.09

• • 이해님(서울대학교 의과대학)

  • 장미희(한국과학기술연구원, 경희대학교)

  • 이창한(서울대학교 의과대학)

  • 김항래(서울대학교 의과대학)

  • 성지혜(서울대학교 의과대학)

  Novel FRET-based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor-T Cell Function

  • Small Methods Sep 11 2024, | https://doi.org/10.1002/smtd.202401016

  • 2024.09
  • 의약학

• • 조예나(숙명여자대학교)

  • 김용기(숙명여자대학교)

  CARM1 phosphorylation at S595 by p38γ MAPK drives ROS-mediated cellular senescence

  • Redox Biol. Available online 6 September 2024, 103344 | https://doi.org/10.1016/j.redox.2024.103344

  • 2024.09
  • 생명과학

• • 이지훈(전남대학교)

  Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies

  • Cancer Treat. Rev. Aug 05 2024, 129 S0305-7372(24)00136-1 | https://doi.org/10.1016/j.ctrv.2024.102808

  • 2024.08

• • 이장순(University of Hawai'I Cancer Center)

  • 임석아(서울대학교 의과대학)

  The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overex

  • J. Exp. Clin. Cancer Res. Aug 21 2024, 43 (1) 236 | https://doi.org/10.1186/s13046-024-03143-3

  • 2024.08

• • 김종승(고려대학교)

  RNA-Activatable Near-Infrared Photosensitizer for Cancer Therapy

  • J. Am. Chem. Soc. Aug 31 2024, | https://doi.org/10.1021/jacs.4c09470

  • 2024.08

• • Duy-Thuc Nguyen(서울대학교 약학대학)

  • 백민준(서울대학교 약학대학 (현 Massachusetts General Hospital and Harvard Medical School))

  • 이재영(서울대학교 약학대학)

  • 김대덕(서울대학교)

  Photobleaching-mediated charge-convertible cyclodextrin nanoparticles achieve deep tumour penetration for rectal cancer theranostics

  • Nat. Nanotechnol. 21 August 2024 | https://doi.org/10.1038/s41565-024-01757-4

  • 2024.08
  • 바이오·의료융합

• • 조유나(부산대학교 의과대학)

    Interview

  • 홍창완(부산대학교 의과대학)

  Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8+ T and CAR-T cells

  • Mol. Ther. August 21, 2024 | https://doi.org/10.1016/j.ymthe.2024.08.019

  • 2024.08
  • 의약학

• • 신성영(Monash University)

  Integrative Modeling of Signaling Network Dynamics Identifies Cell Type-selective Therapeutic Strategies for FGFR4-driven Cancers

  • Cancer Res. Aug 01 2024, | https://doi.org/10.1158/0008-5472.CAN-23-3409

  • 2024.08

• • 임성훈(연세대학교)

  • 이혜성(연세대학교)

  • 민도식(연세대학교)

  PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways

  • Exp. Mol. Med. Jul 01 2024, | https://doi.org/10.1038/s12276-024-01260-9

  • 2024.07
  • 생명과학

• • 김형윤(연세대학교)

  • 조성민(연세대학교)

  • 김성훈(연세대학교 약학대학 & 의과대학, 세브란스병원)

  Specific targeting of cancer vaccines to antigen-presenting cells via an endogenous TLR2/6 ligand derived from cysteinyl-tRNA synthetase 1

  • Mol. Ther. Available online 25 July 2024 | https://doi.org/10.1016/j.ymthe.2024.07.014

  • 2024.07
  • 의약학

• • 최윤정(시프트바이오, 고려대학교)

  • 김성아(고려대학교, 한국과학기술연구원)

  • 남기훈(시프트바이오, 고려대학교)

  • 권민수(울산대학교 의과대학)

  • 김인산(고려대학교, 한국과학기술연구원)

  Novel insights into paclitaxel‘s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment

  • J. Immunother. Cancer Jul 15 2024, 12 (7) e008864 | https://jitc.bmj.com/content/12/7/e008864

  • 2024.07
  • 의약학

• • 박미향(경북대학교)

  • 변준규(경북대학교 약학대학)

  • 최연경(칠곡경북대학교병원)

  • 박근규(경북대학교 의과대학)

  Targeting YAP Activity and Glutamine Metabolism Cooperatively Suppresses Tumor Progression by Preventing Extracellular Matrix Accumulation

  • Cancer Res. Jul 29 2024, | https://doi.org/10.1158/0008-5472.CAN-23-3933

  • 2024.07
  • 의약학

• • Shanika Karunasagara(단국대학교)

  • Ali Taghizade(단국대학교)

  • 김상현(단국대학교)

  • 현정은(단국대학교)

  • 김해원(단국대학교 조직재생공학연구원/치과대학)

  Tissue Mechanics and Hedgehog Signaling Crosstalk as a Key Epithelial-Stromal Interplay in Cancer Development

  • Adv. Sci. Jul 08 2024, | https://doi.org/10.1002/advs.202400063

  • 2024.07
  • 의약학

• • 이수현(유빅스테라퓨틱스, 연세대학교)

  • 김화연(연세대학교)

  • 노재석(연세대학교)

  • 송재환(연세대학교)

  • 이송희(유빅스테라퓨틱스)

  UBX-390: A Novel Androgen Receptor Degrader for Therapeutic Intervention in Prostate Cancer

  • Adv. Sci. Jul 03 2024, | https://doi.org/10.1002/advs.202400398

  • 2024.07
  • 생명과학

• • 유영아(Northwestern University Feinberg School of Medicine, 현 AbbVie)

  Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer

  • Cancer Res. Jul 03 2024, | https://doi.org/10.1158/0008-5472.CAN-23-2910

  • 2024.07